2026· Georgian medical news· Vol 376-377, pp.
381-388
· 0 citations
Medicine
TL;DR
The study concludes that administering 200 U of OnaBT-A, significantly decreases the frequency and duration of headaches when compared to 155 U, and recommends considering this dosage for patients who do not accomplish adequate relief with 155 U of OnaBT-A.
In this retrospective uncontrolled cohort, reductions in headache frequency and other clinical improvements were observed during BoNTA treatment in patients with CM and HFEM, and these findings cannot establish the efficacy of BoNTA in HFEM.
F. Jiménez-Jiménez, Alba Cárcamo-Fonfría, Silvina Espada-Rubio et al.· Pharmaceuticals· 0 citations
Background Chronic migraine is a chronic disabling neurological disease and has a significant impact on quality of life. Topiramate and amitriptyline are commonly used for migraine prevention, but treatment decisions should consider their effectiveness and safety profiles. This study aimed to compare the effectiveness...
M. Karami, Amber Hassan, Amal M. Alkhotani et al.· Frontiers in Pain Research· 0 citations
Background. Chronic migraine (CM) is a highly disabling neurological disorder associated with substantial functional impairment and healthcare burden. Preventive therapies targeting calcitonin gene-related peptide (CGRP) pathways and onabotulinumtoxinA have demonstrated efficacy in CM management. This ongoing real-worl...
Background. Patients with chronic migraine (CM) who remain inadequately controlled despite ongoing preventive monotherapy represent a particularly challenging population. Whether the clinical benefit achieved after adding a second preventive therapy can be maintained over the long term remains poorly understood. Herein...
Background. OnabotulinumtoxinA (BoNT-A) is a well-established preventive treatment for chronic migraine (CM). Given the high burden of CM, many patients require additional preventive therapy for adequate disease control. Although BoNT-A plus anti-CGRP treatments may provide synergistic benefits, real-world evidence rem...